Synjardy is a prescription medication combining empagliflozin (12.5mg) and metformin hydrochloride (1000mg) in film-coated tablet form. Manufactured by Boehringer Ingelheim, this pack contains 60 tablets for oral use in the treatment of type 2 diabetes mellitus. This medication combines two diabetes medicines - empagliflozin (a sodium-glucose co-transporter 2 (SGLT2) inhibitor) and metformin (a biguanide). It is indicated for adults with type 2 diabetes as an adjunct to diet and exercise to improve glycemic control. The tablets should be taken as prescribed by a healthcare provider. This is a prescription-only medication that requires regular medical monitoring.